D004311ProceduresE05.318.780.300E05.581.500.300N05.715.360.780.320N06.850.520.445.3001165030.892567Double-Blind MethodFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson2.391480.00455195116research area of0.3857860.0119182483subject area fortrue1ProfessorProfessorRobertMcCarthyRobert McCarthy350081McCarthy, Robert0000-0002-0966-5311Professortrue1ProfessorProfessorAnesthesiologyInternal Medicine, CardiologyPsychiatryMarkPollackMark Pollack41.87724600000000-87.66843480000000349127Pollack, MarkProfessorRamiDoukkyRami Doukky349247Doukky, RamiProfessorChristopherGoetzChristopher Goetz349622Goetz, ChristopherProfessorJohnZajeckaJohn Zajecka349738Zajecka, JohnProfessor4Professor20625362Simon NM, Worthington JJ, Moshier SJ, Marks EH, Hoge EA, Brandes M, Delong H, Pollack MHCNS spectrumsDuloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response. CNS Spectr. 2010 Jul; 15(7):367-73.CNS Spectr2010-07-01T00:00:002010Duloxetine for the treatment of generalized social anxiety disorder: a preliminary randomized trial of increased dose to optimize response.Neurological SciencesRush University, Rush Medical Collegetrue1ProfessorProfessortrue1ProfessorProfessor37366164Gupta PK, Maheshwari S, Cherian JJ, Goni V, Sharma AK, Tripathy SK, Talari K, Pandey V, Sancheti PK, Singh S, Bandyopadhyay S, Shetty N, Kamath SU, Prahaldbhai PS, Abraham J, Kannan S, Bhat S, Parshuram S, Shahavi V, Sharma A, Verma NN, Kumar UThe American journal of sports medicineEfficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study. Am J Sports Med. 2023 07; 51(9):2254-2266.Am J Sports Med2023-06-27T00:00:002023Efficacy and Safety of Stempeucel in Osteoarthritis of the Knee: A Phase 3 Randomized, Double-Blind, Multicenter, Placebo-Controlled Study.37639777Keary C, Bird LM, de Wit MC, Hatti S, Heimer G, Heussler H, Kolevzon A, Mathews A, Ochoa-Lubinoff C, Tan WH, Yan Y, Adams MEuropean journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology SocietyGaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study. Eur J Paediatr Neurol. 2023 Nov; 47:6-12.Eur J Paediatr Neurol2023-08-01T00:00:002023Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study.37530822Jones J, Correll DJ, Lechner SM, Jazic I, Miao X, Shaw D, Simard C, Osteen JD, Hare B, Beaton A, Bertoch T, Buvanendran A, Habib AS, Pizzi LJ, Pollak RA, Weiner SG, Bozic C, Negulescu P, White PFThe New England journal of medicineSelective Inhibition of NaV1.8 with VX-548 for Acute Pain. N Engl J Med. 2023 Aug 03; 389(5):393-405.N Engl J Med2023-08-03T00:00:002023Selective Inhibition of NaV1.8 with VX-548 for Acute Pain.37988976GomezMancilla B, Meriggioli MN, Genge A, Roubenoff R, Espi? P, Dupuy C, Hartmann N, Pezous N, Kinhikar A, Tichy M, Dionne A, Vissing J, Andersen H, Schoser B, Meisel A, Jordan B, Devlikamova F, Poverennova I, Stuchevskaya F, Lin TS, Rush JS, Gergely PJournal of clinical neuroscience : official journal of the Neurosurgical Society of AustralasiaEfficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study. J Clin Neurosci. 2024 Jan; 119:76-84.J Clin Neurosci2023-11-20T00:00:002023Efficacy and safety of iscalimab, a novel anti-CD40 monoclonal antibody, in moderate-to-severe myasthenia gravis: A phase 2 randomized study.true1ProfessorProfessor